Please assess the completion status of the following clinical trial:

Trial Title: Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* End stage renal disease (ESRD) requiring hemodialysis~* On hemodialysis for ≤ 2 calendar months or scheduled to begin hemodialysis within 1 calendar month~* ≥50 years of age~* Documented Ejection Fraction \> 35% within the previous calendar year~* - If the patient has been hospitalized for a myocardial infarction or heart failure decompensation, the Ejection Fraction measurement must have occurred during the last hospitalization or after discharge~Exclusion Criteria:~* Is receiving or will receive hemodialysis due to acute kidney injury and is not expected to receive subsequent chronic hemodialysis therapy~* Patient has an active ICD~* Patient has a unipolar pacemaker~* Patient has physical or mental conditions preventing him/her from interacting with or wearing a Wearable Cardioverter Defibrillator~* Patient has a chest circumference at the level of the xiphoid of \< 24 inches~* Patient has a chest circumference at the level of the xiphoid of \> 56 inches~* Patient has an advance directive prohibiting resuscitation~* Patient has cancer or other terminal disease (excluding ESRD) with expected survival less than 6 months~* Patient is medically unstable for reasons not specifically related to kidney disease~* Patient is scheduled for live-donor kidney transplantation within 6 calendar months~* Patient is unable to consent

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Wearable Cardioverter Defibrillator (Type: EXPERIMENTAL): End Stage Renal Disease (ESRD) patients beginning hemodialysis will use a Wearable Cardioverter Defibrillator for six months
- Conventional Treatment (Type: NO_INTERVENTION): Conventional Treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).